Protocol for generating human CAR-engineered macrophages by Vpx-containing lentivirus

Human-derived macrophages are notoriously difficult to infect with HIV-1-based lentiviruses, posing a limitation to the advancement of chimeric antigen receptor macrophage (CAR-M) therapy. Here, we present a protocol for generating human chimeric antigen receptor (CAR)-engineered macrophages using the viral protein Vpx (encoded by the Sooty Mangabey simian immunodeficiency virus [SIV] and HIV-2 lineages) incorporated into the lentivirus vector, which enhances infection efficiency. We describe steps for cell cultivation, lentivirus production, concentration, infection procedures, and efficiency assessments. This protocol provides a foundation to study macrophage manipulation, especially with CAR or other immune engagers. For complete details on the use and execution of this protocol, please refer to Gao et al.<sup>1</sup>.

Authors

Institutions

Publication Details

Journal
STAR Protocols
Published
2024-09-28
DOI
https://doi.org/10.1016/j.xpro.2024.103350
Citations
5
Primary Topic
Virus-based gene therapy research
Type
article
Field-Weighted Citation Impact
2.75

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Protocol for generating human CAR-engineered macrophages by Vpx-containing lentivirus

Yun Gao, Yun Gao, Luo Zhang, Xiaobin Fang
5 citations
STAR Protocols
Virus-based gene therapy research
2.75
article

Protocol for generating human CAR-engineered macrophages by Vpx-containing lentivirus

Yun Gao, Yun Gao, Luo Zhang, Xiaobin Fang
article en
5 citations

Abstract

Human-derived macrophages are notoriously difficult to infect with HIV-1-based lentiviruses, posing a limitation to the advancement of chimeric antigen receptor macrophage (CAR-M) therapy. Here, we present a protocol for generating human chimeric antigen receptor (CAR)-engineered macrophages using the viral protein Vpx (encoded by the Sooty Mangabey simian immunodeficiency virus [SIV] and HIV-2 lineages) incorporated into the lentivirus vector, which enhances infection efficiency. We describe steps for cell cultivation, lentivirus production, concentration, infection procedures, and efficiency assessments. This protocol provides a foundation to study macrophage manipulation, especially with CAR or other immune engagers. For complete details on the use and execution of this protocol, please refer to Gao et al.<sup>1</sup>.

STAR ProtocolsVol. 5(4)
Chinese PLA General Hospital (CN), Suzhou Research Institute (CN)
Innovative Research Group Project of the National Natural Science Foundation of China, National Natural Science Foundation of China
Zero hunger
Openalex Percentile: Top 9%
Virus-based gene therapy research
2.75
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.